v3.26.3
SHARE-BASED COMPENSATION - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total share-based compensation expense $ 3,653 $ 3,406 $ 11,200 $ 9,440
Total share-based compensation expense, amount capitalized $ 90 110 $ 490 650
Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 2.50  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 5.14   $ 5.14  
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total share-based compensation expense $ 833 1,009 $ 3,199 2,819
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total share-based compensation expense $ 2,820 2,397 $ 8,001 6,614
Restricted Stock Units (RSUs) | Equity Option        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     1,861,338  
Granted, nonvested, number of shares (in shares)     445,902  
Vested, number of shares (in shares)     (1,141,833)  
Forfeited, number of shares (in shares)     (177,358)  
Number of nonvested shares, end of period (in shares) 988,049   988,049  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 6.22  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     22.34  
Vested, weighted average grant date fair value (in dollars per share)     6.90  
Forfeited (in dollars per share)     8.36  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 12.31   $ 12.31  
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total share-based compensation expense $ 0 $ 0 $ 0 $ 7
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]        
Number of nonvested shares, beginning of period (in shares)     1,003,250  
Granted, nonvested, number of shares (in shares)     0  
Exercised, number of shares (in shares)     (82,495)  
Forfeited, number of shares (in shares)     0  
Expired (in shares)     0  
Number of nonvested shares, end of period (in shares) 920,755   920,755  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 6.67  
Granted, nonvested, weighted average grant date fair value (in dollars per share)     0  
Exercised (in dollars per share)     6.71  
Forfeited (in dollars per share)     0  
Expired (in dollars per share)     0  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 6.67   $ 6.67  
Number of shares, exercisable (in shares) 920,755   920,755  
Exercisable (in dollars per share) $ 6.67   $ 6.67  
Weighted Average Remaining Contractual Life (Years), Outstanding     6 months 14 days  
Intrinsic value, outstanding $ 4,016   $ 4,016  
Exercisable, Intrinsic value $ 4,016   $ 4,016  
Weighted Average Remaining Contractual Life (Years), Exercisable     6 months 14 days